What is GNTA's earnings growth forecast for 2025-2025?
(NASDAQ: GNTA) Genenta Science Spa's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 9.69%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.82%.
Genenta Science Spa's earnings in 2025 is -$9,687,494.
In 2025, GNTA is forecast to generate -$19,570,157 in earnings, with the lowest earnings forecast at -$19,570,157 and the highest earnings forecast at -$19,570,157.
What is GNTA's forecast return on equity (ROE) for 2025-2028?
(NASDAQ: GNTA) forecast ROE is N/A, which is considered weak.
What is GNTA's Earnings Per Share (EPS) forecast for 2025-2025?
(NASDAQ: GNTA) Genenta Science Spa's current Earnings Per Share (EPS) is -$0.53. In 2025, GNTA's EPS is forecast to hit -$1.07 (min: -$1.07, max: -$1.07).
What is GNTA's forecast return on assets (ROA) for 2025-2028?
(NASDAQ: GNTA) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 44.42%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.